(Q47330935)

14 January 2018

title

Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial (English)

1 reference

14 January 2018

1 reference

1 reference

venous thromboembolism

1 reference

1 reference

S K Das

1

1 reference

14 January 2018

A T Cohen

2

1 reference

14 January 2018

R A Edmondson

3

1 reference

14 January 2018

E Melissari

4

1 reference

14 January 2018

V V Kakkar

5

1 reference

14 January 2018

publication date

1 June 1996

1 reference

14 January 2018

published in

World Journal of Surgery

1 reference

14 January 2018

volume

20

1 reference

14 January 2018

issue

5

1 reference

14 January 2018

page(s)

521-6; discussion 526-7

1 reference

14 January 2018

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Chondrodysplasia punctata after warfarin in early pregnancy. Case report and summary of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Hazards of oral anticoagulants during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: a co-operative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Low molecular weight heparin in prevention of perioperative thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Heparin in the initial treatment of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900081

Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin

21 January 2018

1 reference

12 December 2020

Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis

1 reference

12 December 2020

Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis

1 reference

12 December 2020

The I 125 -labeled fibrinogen test and phlebography in the diagnosis of deep vein thrombosis

1 reference

12 December 2020

Low molecular weight heparin

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002689900081

1 reference

14 January 2018

1 reference

14 January 2018